Effect of psychostimulant medications on physical function in children with cerebral palsy: scoping review

Pediatr Res. 2024 Apr;95(5):1217-1223. doi: 10.1038/s41390-023-02933-3. Epub 2023 Dec 9.

Abstract

The aim of this scoping review is to examine the extent and depth of the literature on effects of central nervous system (CNS) stimulant medications on physical function in children with cerebral palsy (CP). A systematic search for relevant peer-reviewed studies was conducted of PubMed, CINAHL, Cochrane, SPORTDiscus, Embase, & Scopus (January 2002 & August 2022). We included studies that examined the effects of CNS stimulants on physical function in children with CP. Four studies met our selection criteria. All studies explored the effect of Modafinil on physical function outcomes. Three studies of the four included studies reported positive effects of Modafinil on spasticity, motor performance, and gait, whereas one study reported no significant effects of Modafinil. Our findings suggest that there is very low-quality evidence that suggests that Modafinil may enhance physical improvements in body structure and function, including reduction in spasticity and improvements in gait parameters. IMPACT: Central nervous system stimulants were examined for efficacy on physical function and spasticity in children with cerebral palsy. The evidence on the effects of central nervous system stimulants on physical function in children with CP is limited and inconsistent.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Central Nervous System Stimulants* / therapeutic use
  • Cerebral Palsy* / drug therapy
  • Cerebral Palsy* / physiopathology
  • Child
  • Gait / drug effects
  • Humans
  • Modafinil* / therapeutic use
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / physiopathology
  • Treatment Outcome

Substances

  • Central Nervous System Stimulants
  • Modafinil